Vitamin E found to reduce period pain

- Last updated on GMT

Related tags: Menstrual cycle, Thiamine

Taking daily vitamin E supplements can significantly reduce the
severity and duration of period pain, and limit blood loss,
according to new research.

A team from Tarbait Modarres University in Iran studied just under 280 teenage girls with primary dysmenorrhoea, a condition that affects around 40 per cent of women.

About 10 per cent of women experience pain that is severe enough to disrupt their daily activities.

The Iranian girls, aged between 15-17, took 200 IU of vitamin E twice a day or a placebo over four consecutive menstrual periods.

They were asked to rate the pain they experienced during each period, and how many painkillers they took. The amount of blood lost was also monitored.

The girls who took vitamin E reported significantly lower intensity of pain, which was reflected in a reduction in the number of painkillers they took, write the researchers in this month's issue of the British Journal of Obstetrics and Gynaecology​ (vol 112, issue 4, pp466).

The vitamin group also experienced shorter duration of pain and less blood loss than the placebo group.

"The use of vitamin E for dysmenorrhoea in adolescent women is attractive because of the marked effect we have demonstrated, coupled with the absence of significant side effects from vitamin E in therapeutic doses,"​ added the authors.

The findings support results reported in the same journal in 2002 that found benefits from taking 500 IU of vitamin E over two consecutive periods.

There is also some evidence that taking thiamine (vitamin B1) or magnesium supplements can help reduce period pains, while new research suggests that fish oil may help reduce pain too.

Related topics: Research, Suppliers, Vitamins & premixes

Related news

Related products

show more

How to Enter UK’s £690M CBD Market

How to Enter UK’s £690M CBD Market

The Association for the Cannabinoid Industry | 18-Jun-2021 | Technical / White Paper

The UK has the world’s most developed regulatory framework for legal cannabinoids, such as CBD and CBG. With a 2021 market estimated to be worth £690 million...

Related suppliers

Follow us

Products

View more

Webinars